前列腺高分辨率微超声与多参数磁共振成像的相关性
本研究评估高分辨率微超声(microUS)与多参数磁共振成像(MP-MRI)在临床显著前列腺癌(csPCa)病灶识别中的相关性。回顾性分析161例接受MP-MRI和经会阴microUS引导穿刺活检的患者,PRI-MUS与PI-RADS呈中度正相关(r=0.40,P<.001),microUS靶向穿刺在8/161(5.0%)患者中检出比系统穿刺和MRI靶向穿刺更高分级疾病,若无microUS靶向采样,4/161(2.5%)患者的csPCa将被漏诊。
要点
- PRI-MUS与PI-RADS呈中度正相关(r=0.40,P<.001)。
- microUS靶向穿刺在8/161(5.0%)患者中检出比系统穿刺和MRI靶向穿刺更高分级疾病。
- 若无microUS靶向采样,4/161(2.5%)患者的csPCa将被漏诊。
核心结论
- microUS/PRI-MUS与MP-MRI/PI-RADS呈中度正相关,且与单独MRI靶向穿刺相比可提高csPCa检出。
- microUS可能有助于联合MP-MRI使用,或作为不适合MRI患者的替代影像学方法。
研究设计与样本
- 回顾性分析前瞻性维护的数据库,纳入2021年2月至2023年4月间连续接受MP-MRI和经会阴microUS引导穿刺活检的267例患者,最终161例符合纳入标准。
- 采用PRI-MUS方案对前列腺病灶进行风险分层,PRI-MUS 3-5定义为阳性;MRI病灶按PI-RADS v2.1分类。
主要发现
- 平均年龄65.6±1.5岁,前列腺特异性抗原7.6±0.6ng/mL。
- 92例患者发现PI-RADS 3-5病灶。
- Spearman相关分析显示PRI-MUS与PI-RADS呈中度正相关(r=0.40,P<.001)。
- microUS靶向穿刺在8/161(5.0%)患者中检出比系统穿刺和MRI靶向穿刺更高分级疾病。
- 若无microUS靶向采样,4/161(2.5%)患者的csPCa将被漏诊。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the correlation between high-resolution microultrasound (microUS) and multiparametric magnetic resonance imaging (MP-MRI) in clinically significant prostate cancer (csPCa) lesion identification. METHODS: We reviewed our prospectively maintained database of 267 consecutive patients who underwent MP-MRI and transperineal microUS-guided biopsy between February 2021 and April 2023. The Prostate Risk Identification using MicroUS (PRI-MUS) protocol was utilized to risk stratify prostate lesions, with PRI-MUS 3-5 defined as positive. MRI lesions were classified according to the Prostate Imaging Reporting and Data System (PI-RADS) version 2.1. Clinicopathologic outcomes were analyzed. Spearman correlation testing was computed to assess the relationship between PRI-MUS and PI-RADS. RESULTS: A total of 161 patients met inclusion criteria. Mean±standard deviation age was 65.6±1.5years and prostate-specific antigen was 7.6±0.6ng/mL. Ninety-two patients were found to have PIRADS 3-5 lesions. Spearman correlation analysis revealed a moderate positive correlation between PRI-MUS and PI-RADS (r=0.40, P<.001). MicroUS-targeted cores detected higher grade disease than systematic and MRI-targeted cores in 8/161 (5.0%) patients. CsPCa would have been missed in 4/161 (2.5%) patients without microUS-targeted sampling. CONCLUSION: MicroUS/PRI-MUS demonstrates moderate positive correlation with MP-MRI/PI-RADS and offers improved csPCa detection compared to MRI-targeted biopsy alone. MicroUS may be useful in conjunction with MP-MRI or as an alternative imaging modality in MRI-ineligible patients.
引用
- Pickersgill NA, Alkazemi MH, Ostergar A, et al. Correlation of Prostate High-Resolution Microultrasound With Multiparametric Magnetic Resonance Imaging. Urology. 2024. PMID: 39615700. doi:10.1016/j.urology.2024.11.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。